Redner's Pharmacy #46 Pharmacy Location: 22 Forest Dr, Hegins, Pennsylvania 17938 Phone: (570) 680-3855 |
News Archive
Researchers have launched a clinical trial to evaluate the drug candidate DEX-M74 as a treatment for a rare degenerative muscle disease, hereditary inclusion body myopathy (HIBM). National Institutes of Health scientists from the National Center for Advancing Translational Sciences (NCATS) and the National Human Genome Research Institute (NHGRI) will conduct the clinical trial at the NIH Clinical Center.
The UN has said that population aging is "transforming the world." Now that a large portion of the world population is joining the ranks of the "baby boomers," the phenomenon is permeating many areas of life, including the economic, medical, moral, political, and social. In the U.S., as of 2008 (the last time data was collected), the number of persons 65 or older came to 38.9 million.
A clinical decision model which uses MR spectroscopy to help physicians differentiate between recurrent tumors and changes in the brain tissue due to radiation treatments, may help patients avoid invasive procedures and treatments, according to a study performed at the University of Michigan Health System in Ann Arbor, MI.
Biota Holdings Limited today announced that Daiichi Sankyo has received approval to manufacture and market InavirĀ® in Japan. InavirĀ® is Daiichi Sankyo's brand of laninamivir octanoate and also previously known as CS-8958. The approved indication is for the treatment of influenza in adults and children.
› Verified 8 days ago